IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 56,594,046
- Share change
- +11,034,490
- Total reported value
- $1,329,917,026
- Put/Call ratio
- 387%
- Price per share
- $23.50
- Number of holders
- 138
- Value change
- +$272,378,345
- Number of buys
- 99
- Number of sells
- 47
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avidity Partners Management LP |
13F
|
Company |
4.2%
|
3,673,400
|
$50,435,782 | — | 31 Mar 2023 | |
| Logos Global Management LP |
13F
|
Company |
4.1%
|
3,600,000
|
$49,428,000 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4%
|
3,549,093
|
$48,729,048 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3.3%
|
2,864,607
|
$39,331,054 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3%
|
2,676,559
|
$36,749,155 | — | 31 Mar 2023 | |
| Canaan Partners X LLC |
13F
|
Company |
3%
|
2,660,713
|
$36,531,589 | — | 31 Mar 2023 | |
| BVF INC/IL |
13F
|
Company |
2.8%
|
2,455,089
|
$33,708,372 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.6%
|
2,320,998
|
$31,867,302 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
2.5%
|
2,202,812
|
$30,245,000 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
2,114,317
|
$29,029,572 | — | 31 Mar 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2%
|
1,743,628
|
$23,940,012 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.7%
|
1,466,587
|
$20,137,000 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
1,036,451
|
$14,229,893 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
1,011,116
|
$13,882,623 | — | 31 Mar 2023 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.99%
|
868,520
|
$11,924,780 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.98%
|
859,934
|
$11,806,898 | — | 31 Mar 2023 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.95%
|
835,521
|
$11,471,703 | — | 31 Mar 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.95%
|
832,769
|
$11,433,918 | — | 31 Mar 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.75%
|
657,897
|
$9,046,078 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.66%
|
581,519
|
$7,984,256 | — | 31 Mar 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.53%
|
468,358
|
$6,430,555 | — | 31 Mar 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.52%
|
453,149
|
$6,221,736 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.49%
|
433,682
|
$5,954,453 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
404,503
|
$5,553,827 | — | 31 Mar 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.4%
|
350,000
|
$4,806,000 | — | 31 Mar 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
0.39%
|
343,000
|
$4,709,390 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
0.39%
|
340,216
|
$4,671,166 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.37%
|
324,410
|
$4,454,149 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.32%
|
282,100
|
$3,873,233 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.32%
|
280,317
|
$3,542,524 | — | 31 Mar 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.29%
|
253,480
|
$3,480,280 | — | 31 Mar 2023 | |
| Michael P. Dillon |
3/4/5
|
SVP, Chief Scientific Officer |
—
mixed-class rows
|
102,226
mixed-class rows
|
$3,311,116 | — | 04 Oct 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.27%
|
238,907
|
$3,280,000 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
191,729
|
$2,632,439 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
175,546
|
$2,410,246 | — | 31 Mar 2023 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.19%
|
165,200
|
$2,268,196 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
153,901
|
$2,113,061 | — | 31 Mar 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.16%
|
138,949
|
$1,907,770 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.15%
|
127,633
|
$1,752,401 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
119,203
|
$1,636,657 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.13%
|
117,400
|
$1,611,902 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.12%
|
104,160
|
$1,430,117 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.11%
|
97,059
|
$1,332,620 | — | 31 Mar 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.11%
|
92,411
|
$1,268,803 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
90,752
|
$1,246,024 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.09%
|
83,000
|
$1,139,590 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.08%
|
73,855
|
$1,014,029 | — | 31 Mar 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.08%
|
70,000
|
$961,100 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
69,211
|
$950,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
63,903
|
$877,388 | — | 31 Mar 2023 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2023
As of 30 Jun 2023,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,594,046 shares.
The largest 10 holders included
BVF INC/IL, BlackRock Inc., FEDERATED HERMES, INC., Avidity Partners Management LP, VANGUARD GROUP INC, Canaan Partners X LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Boxer Capital, LLC.
This page lists
138
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
127
Q2 2023 holders
138
Holder diff
11
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.